Skip to main content
DC 7718Hematologic & Lymphatic System38 CFR § 4.117

Essential thrombocythemia and primary myelofibrosis

VA disability rating criteria for Essential thrombocythemia and primary myelofibrosis under Diagnostic Code 7718. The VA assigns ratings of 0%, 30%, 70%, 100% based on the severity and functional impact of your condition.

Rating Criteria

0%Disability Rating

Asymptomatic

30%Disability Rating

Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count of 200,000-400,000, or white blood cell (WBC) count of 4,000-10,000

70%Disability Rating

Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 &#xD7; 10/L 9

100%Disability Rating

Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment

Get a Personalized Rating Analysis

AIDEN can analyze your specific symptoms, identify secondary connections, and help you understand what rating you may qualify for based on your medical evidence.

Talk to AIDEN